Granules India

Granules India, headquartered in India, is a pharmaceutical company within the Chemicals nec industry. In 2025, the company reported total carbon emissions of 544,329,000 kg CO2e. This includes Scope 1 emissions of 57,414,000 kg CO2e, Scope 2 market-based emissions of 18,853,000 kg CO2e, and Scope 3 emissions totalling 468,062,000 kg CO2e. Key categories within Scope 3 emissions for 2025 included purchased goods and services at 360,046,000 kg CO2e, and processing of sold products at 29,905,000 kg CO2e.

Looking back, Granules India's emissions for 2024 were approximately 621,723,000 kg CO2e, with Scope 1 at 56,254,000 kg CO2e, Scope 2 at 31,632,000 kg CO2e, and Scope 3 at 633,837,000 kg CO2e. In 2023, total emissions were 726,684,000 kg CO2e, comprising 56,265,000 kg CO2e for Scope 1, 56,306,000 kg CO2e for Scope 2 market-based emissions, and 614,113,000 kg CO2e for Scope 3.

Granules India has set ambitious climate commitments, with all targets directly set by Granules India Limited. The company aims for Net-Zero greenhouse gas emissions across its value chain by FY2050, aligned with the Science Based Targets initiative (SBTi) 1.5°C pathway.

Near-term targets include an absolute reduction of Scope 1 and 2 GHG emissions by 42% by FY2030 from a FY2023 base year. The company also commits to increasing active annual sourcing of renewable electricity from 0% in FY2023 to 100% in FY2030. Furthermore, Granules India aims to reduce absolute Scope 3 GHG emissions by 42% by FY2030 from a FY2023 base year.

For the long-term, by FY2050, Granules India commits to reducing absolute Scope 1 and 2 GHG emissions by 90% from a FY2023 base year, and to reduce absolute Scope 3 GHG emissions by 90% within the same timeframe.